Mark Okey Decker Jr - Jun 23, 2025 Form 4 Insider Report for Global Medical REIT Inc. (GMRE)

Role: CEO and President, Director
Signature: /s/ Jamie Barber, as Attorney-in-Fact
Stock symbol: GMRE
Transactions as of: Jun 23, 2025
Transactions value $: $1,042,528
Form type: 4
Date filed: 6/25/2025, 08:24 PM
Previous filing: Oct 2, 2024
Next filing: Aug 18, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Decker Mark Okey Jr	CEO and President, Director	7373 WISCONSIN AVENUE, SUITE 800, BETHESDA	/s/ Jamie Barber, as Attorney-in-Fact	2025-06-25	0001681625

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GMRE	Common Stock	Purchase	$653K	+100K		$6.53	100K	Jun 24, 2025	Direct	F1
transaction	GMRE	Common Stock	Purchase	$17K	+2.67K	+2.67%	$6.37	103K	Jun 24, 2025	Direct	F2
transaction	GMRE	Common Stock	Purchase	$199K	+30.8K	+29.96%	$6.47	133K	Jun 25, 2025	Direct	F3
transaction	GMRE	Common Stock	Purchase	$53K	+8.07K	+6.05%	$6.56	141K	Jun 25, 2025	Direct	F4
transaction	GMRE	Common Stock	Purchase	$121K	+18.5K	+13.08%	$6.54	160K	Jun 25, 2025	Direct	F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GMRE	LTIP Unit (Right to Buy)	Award	$0	+159K		$0.00	159K	Jun 23, 2025	Common Stock	159K		Direct	F6, F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This is the weighted average purchase price. Shares were purchased in multiple transactions at prices ranging from $6.31 to $6.60, inclusive. The amount reflected has been rounded to four decimal points. The reporting person undertakes to provide to Global Medical REIT Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) through (5) to this Form 4.
F2	This is the weighted average purchase price. Shares were purchased in multiple transactions at prices ranging from $6.32 to $6.40, inclusive. The amount reflected has been rounded to four decimal points.
F3	This is the weighted average purchase price. Shares were purchased in multiple transactions at prices ranging from $6.44 to $6.505, inclusive. The amount reflected has been rounded to four decimal points.
F4	This is the weighted average purchase price. Shares were purchased in multiple transactions at prices ranging from $6.555 to $6.585, inclusive. The amount reflected has been rounded to four decimal points.
F5	This is the weighted average purchase price. Shares were purchased in multiple transactions at prices ranging from $6.4925 to $6.615, inclusive. The amount reflected has been rounded to four decimal points.
F6	Represents units of limited partnership interests ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer, that were granted to the Reporting Person under the Issuer's 2016 Equity Incentive Plan (as amended from time to time) in connection with the Reporting Person's appointment as President and Chief Executive Officer, effective June 23, 2025 (the "grant date"). All of the LTIP Units vest on the third anniversary of the grant date.
F7	As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.